Odomzo (Sonidegib)
- Medicine Name: Odomzo
- API: Sonidegib
- Dosage Form & Strength: Capsules: 200 mg
- Manufactured By: Novartis
Odomzo (sonidegib) is a hedgehog pathway inhibitor used for the treatment of adults with locally advanced basal cell carcinoma (BCC) that has come back following surgery or radiation therapy, or those who are not the recipients for surgery or radiation therapy.
Recommended Dosage: The recommended dose of Odomzo is 200 mg administered orally once daily on an empty stomach, at least 1 hour before or 2 hours after a meal, administered until disease progression or unacceptable toxicity. Verify the pregnancy status of females of reproductive potential before starting therapy. Obtain serum creatine kinase (CK) levels and renal function tests before initiating this therapy in all patients. In case a dose of Odomzo is missed, resume dosing with the very next scheduled dose.
- Therapy with Odomzo 200 mg can cause embryo-fetal death or severe birth defects when used to a pregnant woman. Verify the pregnancy status of females of reproductive age before starting this therapy. Females should use highly effective contraception during therapy and for at least 20 months after the final dose.
- Male patients with female partners should use condoms, even after a vasectomy, during therapy with this medicine, and for at least 8 months after the last dose to avoid potential drug exposure in pregnant females or females of reproductive age/potential.
- Patients should not donate blood or blood products while taking treatment with Sonidegib and for at least 20 months after the final dose of Sonidegib because their blood or blood products might be given to a female of reproductive age/potential.
- Musculoskeletal adverse reactions, which may be accompanied by serum creatine kinase (CK) elevations, occur with Sonidegib and other drugs that inhibit the hedgehog pathway. Obtain baseline serum CK and creatinine levels before initiating therapy, periodically during therapy, and as clinically needed (e.g., if muscle symptoms are reported).
What documents are required to import ODOMZO to India?
ODOMZO (sonidegib) capsules can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:
- A valid prescription from a qualified doctor.
- Patients diagnostic reports
- Patients ID proof (issued by the government of India)
The order will be confirmed only after the receipt of:
- A valid prescription from Doctor
- Import permit if applicable
ODOMZO (sonidegib capsules) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input
- On availability of Odomzo in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
- Medicine Price.
- Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
- Ensuring 100% transparency.
IPN (Indian Pharma Network) can facilitate the supply of ODOMZO (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable).
Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Odomzo 200 mg price in India. We take to guarantee quality and delivery anywhere in the world as per the buyer’s requirements.
What is the Generic Name for the trade name drug Odomzo®?
Sonidegib is a Generic Name for the trade name drug Odomzo®.
What is the Manufacturer’s Name of Odomzo®?
Odomzo® is manufactured by Novartis.
Is Odomzo® approved by the FDA?
Yes, Odomzo® is approved by the FDA. Date of first approval: July 24, 2015.
Where can I get Odomzo® at the best price in India?
To get the best Odomzo price in India, kindly contact the Indian Pharma Network (a WHO GDP and ISO 9001:2008 certified company). For Odomzo®, a medical prescription is needed from a treating physician.
What is the dosage and form of Odomzo® supplied?
Odomzo® is supplied as Capsules: 200 mg for oral administration.
What are the most common side effects of Odomzo®?
The most common side effects of Odomzo® are fatigue, nausea, muscle spasms, alopecia, dysgeusia, abdominal pain, musculoskeletal pain, diarrhea, decreased weight, decreased appetite, myalgia, pain, headache, vomiting, and pruritus.
How much does Odomzo® cost in India?
The cost of Odomzo in India can vary. To procure this hedgehog pathway inhibitor legally, you can call or WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.
What are the storage conditions of Odomzo®?
Store the capsules of Odomzo® at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F).
Is it safe to buy Odomzo® online in India?
Yes, one can buy Odomzo online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can help facilitate the supply of Odomzo® through legal channels.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.